Who do we help?

Our group of prognostic and predictive blood biomarkers – GlyHealth,  reliably measure and track chronic inflammation processes in the body. Unlike current inflammation markers, this is done without interference from acute inflammation and can give early warning signs even at very early subclinical stages of inflammatory diseases. Blood tests based on these biomarkers can also be used to track fitness of immune system and effectiveness of anti-inflammatory intervention


Clinicians and other health care practitioners responsible for the care of patients either with or at risk of developing IDs.


Biopharma companies developing anti-inflammatory therapeutics.